AI-generated summary
The authors report a randomized, placebo-controlled crossover trial of transcranial photobiomodulation in 17 patients with mild traumatic brain injury. After real treatment, participants showed improvements in visual working memory, verbal memory learning, sleep quality, physical symptoms, pain and PTSD symptoms, while no significant change occurred after sham treatment. The sample was small and the authors describe the findings as supporting potential, with further exploration encouraged.
- Participants
- 17
- Who or what was studied
- Patients with mild traumatic brain injury
- Limits stated in the abstract
- The abstract describes a small sample of 17 patients and does not report wavelength or dosing parameters.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Post-traumatic stress disorder, Traumatic brain injury, Photobiomodulation, Brain injury, Sham, Minimal clinically important difference, Functional near-infrared spectroscopy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.